Antibodies
Israeli startup to use AI to transform antibody discovery, design
"The launch of CombinAble heralds a shift in the approach to targeted antibody design by leveraging AI to optimize and expedite the discovery process," said Mati Gill, CEO of AION Labs.
Researchers find new way to make animal antibodies safe for humans
Flu viruses may be combated with new antibody, study finds
Sleeping less than six hours will decrease vaccine effectiveness - study
US signs $1 billion deal for COVID-19 antibody drug
The treament, developed by GSK and Vir Biotechnology, has shown to cut the risk of hospitalization or death by 79% in adults with mild-to-moderate COVID-19.
COVID: Scientists find super-antibody that might help fight new variants
The discovery could help prevent future pandemics as well, scholars at Duke University and the University of North Carolina at Chapel Hill said.
COVID: Israelis to be able to get recovery certificates through serology
Under a new Health Ministry policy, those who undergo an ‘N’ serological test can prove they recovered and receive a green pass with one jab.
Antibody levels decrease after two doses of Pfizer vaccine - study
Over 4,800 staff members of Sheba participated in the study. They were invited to undergo periodical serological tests that measure the level of antibodies in the blood for a period of six months.
Third COVID vaccine seems to be game changer for renal transplant recipients
A study conducted at the Sheba Medical Center using big data shows low immune response in such patients after two shots, but preliminary observations after the booster offer cause for optimism.
COVID: Mild cases at risk of deterioration to be given antibody drug
Regeneron was authorized in November for emergency use by the US Food and Drug Administration (FDA).
COVID-19 treatment solutions are closer than we think
Two recent studies have achieved impressive results in reducing viral load.
Coronavirus: T-cell memory may ensure immunity after antibodies are gone
T cell memory represents a fundamental factor in the immunity against the virus and may be able to ensure protection after the antibodies are gone.
COVID-19: New antibody nasal spray could provide virus protection - study
After the antibody treatment was sprayed into the noses of mice, either six hours before infection or six hours after infection, the amount of virus in their lungs was significantly reduced.
Study identifies antibody from common cold infection that reacts to COVID
The study found that the antibody in question reacts not only to SARS-CoV-2, which causes COVID-19, but also SARS-CoV-1, which causes Severe Acute Respiratory Syndrome (SARS).
